Cancelling out an illness before a child is born offers the most potential benefit.
Gene tinkering opens the door to treatments for an array of diseases
Researcher and entrepreneur Luk Vandenberghe thinks he can transport genes into cells much more efficiently by improving the viral vectors that carry them.
The largest organ in the body is a prime target for gene therapy.
A permissive regulatory climate and a pragmatic approach have fostered soaring growth
A machine learning algorithm uses EEG traces to find a patient’s odds of waking
The gene targeted for its role in HIV is linked to increased severity of other infectious diseases—and has implications for learning in mice
The preliminary announcement comes in the wake of a Trump administration order that agency scientists to stop buying such tissue from humans
Research and development in medical technology is responding to transformative changes in healthcare, not only by developing new products, but by finding new ways to innovate. Singapore has a unique, well-developed healthcare and R&D ecosystem making it an ideal location to trial new systems...
The cross-species heart procedure brings human trials into view
If repeated, the feat may open the door to expanding infertility treatments
After false starts, researchers are making progress toward treating deafness with gene therapy
Disruptive solutions that are poised to change the world
There’s a right way for doctors to integrate technology into patient care
Long-ignored field attracts interest from companies trying to develop next-generation immune therapies
Immuno-Oncology (I-O) resistance has emerged as a major roadblock in cancer research, but scientists aren’t backing down without a fight.
In a YouTube video, the researcher announced the birth of twin girls whose genomes he says were modified with CRISPR to prevent HIV infection
A man in his 50s is the first of seven patients to receive the experimental therapy
A detailed picture of cell types in some areas of the mouse cortex is put to the test
For all their potential, CAR-T cell cancer therapies face significant obstacles. Bijan Nejadnik of Eureka Therapeutics explains one powerful method to overcome them.